Results 21 to 30 of about 22,546,014 (283)

Direct non-medical and indirect costs by 3^rd generation cephalosporin susceptibility status (N = 154).

, 2023
Direct non-medical and indirect costs by 3rd generation cephalosporin susceptibility status (N = 154).
Hendramoorthy Maheswaran (186758), Rebecca Lester (4396492), Nicholas A. Feasey (8190816), James Mango (16425730), Christopher P. Jewell (16425733), Jane Mallewa (314106), David A. Lalloo (16425736)   +6 more
core   +1 more source

The Cost of Von Willebrand Disease in Europe: The CVESS Study

Clinical and Applied Thrombosis/Hemostasis, 2022
Background Von Willebrand disease (VWD) is one of the most common inherited bleeding disorders, imposing a substantial health impact and financial burden.
George Morgan MSc, Sarah Brighton BSc, Mike Laffan BA, BMBCh, DM, FRCP, FRCPath, Jenny Goudemand MD, Bethany Franks MSc, Alan Finnegan PhD, RN, FRCN, FRSA, CF, FAAN   +5 more
doaj   +1 more source

Direct non-medical costs (the cost was calculated based on a Chinese yuan: US dollar ratio of 7.189: 1).

, 2023
Direct non-medical costs (the cost was calculated based on a Chinese yuan: US dollar ratio of 7.189: 1).
Na Li (6550), Guanyan Li (13955389), Qingyue Gao (13955383), Shaofeng Hao (13955380), Ziyou Yuan (13955386), Shengfu Fan (13896345), Changyan Liu (9321797), Jianzhou Yang (4744092), Huilin Li (795365)   +8 more
core   +1 more source

Lyme borreliosis in Belgium: a cost-of-illness analysis

BMC Public Health, 2022
Background Lyme borreliosis (LB) is the most common tick-borne disease in Europe and North America, yet its economic burden remains largely unknown. This study aimed to estimate the economic cost associated with the different clinical manifestations of ...
Laurence Geebelen, Brecht Devleesschauwer, Tinne Lernout, Katrien Tersago, Yves Parmentier, Herman Van Oyen, Niko Speybroeck, Philippe Beutels   +7 more
doaj   +1 more source

Factors associated with total direct medical costs.

, 2023
Factors associated with total direct medical costs.
Wanvisa Udomsinprasert (778569), Jiraphun Jittikoon (9873716), Pattarawalai Talungchit (9566525), Usa Chaikledkaew (4909543), Preechaya Wongkrajang (740241)   +4 more
core   +1 more source

Chronic kidney disease in Spain: analysis of patient characteristics, incidence and direct medical costs (2011-2017) [PDF]

, 2021
To review the characteristics of patients with chronic kidney disease (CKD) who attended primary and specialized care centers in Spain, and to analyze patients' use of medical resources and direct medical costs of specialized ...
Darbà, Josep, Marsà, Alícia
core   +1 more source

Health resource utilization and the economic burden of patients with wet age-related macular degeneration in Thailand

International Journal of Ophthalmology, 2014
AIM:To determine healthcare resource utilization and the economic burden associated with wet age-related macular degeneration (AMD) in ThailandMETHODS:This study included patients diagnosed with wet AMD that were 60 years old or older, and had best ...
Piyameth Dilokthornsakul, Nathorn Chaiyakunapruk, Paisan Ruamviboonsuk, Mansing Ratanasukon, Somsanguan Ausayakhun, Akrapope Tungsomeroengwong, Nattapol Pokawattana, Chalakorn Chanatittarat   +7 more
doaj   +1 more source

The trend of direct medical costs and associated factors in patients with chronic hepatitis B in Guangzhou, China: an eight-year retrospective cohort study

BMC Medical Informatics and Decision Making, 2021
Background Although the expenses of liver cirrhosis are covered by a critical illness fund under the current health insurance program in China, the medical costs associated with hepatitis B virus (HBV) related diseases is not well addressed.
Shuo Yang, Ge Chen, Yueping Li, Guanhai Li, Yingfang Liang, Feng Zhou, Shudong Zhou, Yi Yang, Weidong Jia, Yanhui Gao, Yue Chen   +10 more
doaj   +1 more source

Costs incurred by patients with oral potentially malignant disorders: is there a public health need for financial protection in India?

BMC Research Notes, 2021
Objectives Financial protection mechanisms are in place to overcome the costs of a few diseases in India. Our objective was to estimate the costs incurred due to Oral Potentially Malignant Disorders (OPMD) and to determine predictors of such costs ...
Jay R. Patel, Mihir P. Rupani
doaj   +1 more source

Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)

Сахарный диабет, 2017
Background: Cost-of-Illness Analysis (COI) constitutes the basis for the decision-making process on the budget and allocation in a modern health care system.
Ivan I. Dedov, Marina F. Kalashnikova, Dmitriy Y. Belousov, Aleksey S. Kolbin, Vladimir V. Rafalskiy, Aleksey E. Cheberda, Mariya A. Kantemirova, Vadim D. Zakiev, Valentin V. Fadeyev   +8 more
doaj   +1 more source